IPA (ImmunoPrecise) Market Capitalization

The Canadian business ImmunoPrecise Antibodies (IPA) is based on providing antibody research services, with the firm's operational resilience critically dependent on external chemical component suppliers. This chart reflects the stock price action fixed at 0.10. Global tensions are driving demand for defensive developments, although trade restrictions complicate collaboration with foreign research centers.

ImmunoPrecise Antibodies Ltd - IPA Market Capitalization (period 07/04/2022 - 09/04/2025)

Metric breakdowns and analytics for immunoprecise.com (IPA)

- market price and analyst price targets:

Price Chart ImmunoPrecise Antibodies Ltd.|IPA - Forecast Levels Chart

- business market valuation indicators:

Market Capitalization ImmunoPrecise Antibodies Ltd.|IPA - Enterprise Value

- issuer book value statistics:

Book Value per Share ImmunoPrecise Antibodies|IPA - Accounting Capitalization|Market Value to Book Value Ratio immunoprecise.com|IPA - Total Business Assets

- issuer credit burden and liquidity indicators:

Total Debt to Capital ImmunoPrecise Antibodies|IPA - Long-Term Debt to Capital|Short-Term Debt to Capital ImmunoPrecise Antibodies Ltd.|IPA - Company Total Debt Obligations|Debt to Book Capitalization Ratio ImmunoPrecise Antibodies Ltd.|IPA - Company Long-Term Liabilities|Company Short-Term Debt ImmunoPrecise Antibodies|Quick Liquidity Indicator immunoprecise.com

- financial results and valuation multiples details:

IPA - Net Profit|Expected Profit ImmunoPrecise Antibodies|IPA - Price to Earnings Multiple|Future Price to Earnings ImmunoPrecise Antibodies Ltd.|IPA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImmunoPrecise Antibodies Ltd.|IPA - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months ImmunoPrecise Antibodies|IPA - Earnings per share for the trailing year|Quarterly EPS earnings growth immunoprecise.com|IPA - Earnings per share growth rate in current year|Earnings growth forecast for next year ImmunoPrecise Antibodies

Comprehensive company analysis:IPA (ImmunoPrecise)

Investors utilize this tool to stress-test assets during periods of volatility. ImmunoPrecise Antibodies (IPA) is currently scaling AI platforms for antibody discovery, expanding partnerships with biopharma behemoths. The total value of all shares, reflected through the issuer's market value on the exchange, measures the aggregate capital of the owners. This trend captures hidden business issues prior to the publication of financial statements. This allows for an objective assessment of the market scale of the high-tech enterprise.

Competitors of ImmunoPrecise Antibodies (IPA)